spacer
home > pmps > spring 2018 > fight against counterfeit drugs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Fight Against Counterfeit Drugs

Among the myriad of challenges faced by the pharmaceutical industry, the challenge of counterfeit drugs is probably the greatest. It not only causes tremendous revenue losses, but also negatively impacts a company’s reputation and brand image. Most importantly, the miseries inflicted by it on human life are simply incalculable.

Counterfeit drugs are not only threatening the confidence in healthcare professionals and health programmes, but they are also increasing the burden on healthcare systems, national medicine regulatory authorities, law enforcement, and criminal justice systems. According to industry estimates, counterfeit medicines sales are ranging from €150-€200 billion (US$163-$217 billion) per year (1). To counter this increasing threat, government bodies in most countries are devising more robust and strict regulations to control the genesis and proliferation of fake medicines. Track-and-trace, along with pharma product serialisation, is the next firm step towards winning this fight.

The Increasing Serialisation Trend

Serialisation entails encoding of each pharma product coming off a packaging line with a unique identification code that can be traced at each point throughout the supply chain. The unique identification code can be stored into an online database along with the other valuable information about the product, such as manufacturer and batch details, thus allowing for monitoring and tracing the journey of each product, from packaging line right up to the patient. Currently, serialisation regulations are at different phases of development in various countries. To match these country-specific deadlines, most of the global pharma companies need to be track-and-trace- and serialisation-ready.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gaurav Mohite at ACG Inspection Systems has over six years of expertise in holistic track-andtrace solutions for the pharma industry. He was part of the complete trackand- trace implementation team across all the ACG implementation globally. Gaurav had completed his master’s for Jamnalal Bajaj Institute of Management Studies, India, in marketing and bachelor degree in engineering. At the early stage of his professional career, he had worked on vision inspection systems and track-and-trace applications as developer and business analyst throughout the industry. Gaurav is currently working as product manager and working for product marketing, strategy planning, and technologic innovations.
spacer
Gaurav Mohite
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

RWS Life Sciences Welcomes New VP of Quality

RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and Process, in charge of the strategic direction and implementation of its Quality system, underlying organizational processes, and change management.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

SMi’s 9th Annual Biosimilars & Biobetters Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018, SMi deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement